Dexmeto 100 mcg Injection

Regulated Product — Business License Required

B2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.

Product photography not yet supplied — this space will show official packaging imagery once provided by the business.

Product Overview

Dexmeto 100 mcg Injection contains dexmedetomidine, an alpha-2 adrenergic agonist used as a sedative. Its labelling describes it for sedating adults in intensive care settings and for helping put patients to sleep and relieving pain before, during, or after treatment. It is given only by a doctor, into the veins, in an intensive care setting; a non-professional or the patient can never use it alone. While the patient is sedated, the doctor monitors heart rate, breathing rate, blood pressure, and oxygen level.

Active ingredient
Dexmedetomidine (as hydrochloride)
Strength
100 mcg
Dosage form
Concentrate for solution for infusion
Therapeutic class
Alpha-2 adrenergic agonist (sedative)
Regulatory status
Prescription / regulated — confirmed per enquiry and destination market
Availability
Confirmed per enquiry

Product Information

The following description reflects information associated with this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.

Described Uses

  • Described as a sedative for adults in intensive care settings
  • Described as helping put patients to sleep and relieving pain before, during, or after treatment
  • Described as modulating the action of certain chemical messengers in the brain responsible for pain relief and sleep
Note: SDO Pharma has not independently verified the manufacturer’s efficacy claims for this product and makes no additional medical or clinical claims beyond what is described here. We do not claim FDA, UAE, EU, or other specific regulatory approval for this product unless independently verified. This is a prescription / regulated-status product; patient dispensing is the responsibility of the licensed business customer, not SDO Pharma.

Described Dosage & Administration

  • Given only by a doctor, into the veins, in an intensive care setting
  • Never used by a non-professional or by the patient alone
  • Heart rate, breathing rate, blood pressure, and oxygen level are monitored during sedation

Described Side Effects

Commonly described side effects include:

  • Decreased blood pressure
  • Dryness in the mouth
  • Slow heart rate

These are described as commonly temporary. The doctor should be notified immediately if they persist.

Precautions

  • The doctor should be informed about pregnancy or breastfeeding
  • A complete medical history should be shared with the doctor
  • Any common side effect that persists should be reported to the doctor immediately

This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.

B2B, Import & Export

B2B, Import & Export Enquiries

SDO Pharma supports business enquiries for pharmaceutical and healthcare products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.

We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.

Product Enquiry

Request Product Information

Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.

Frequently Asked Questions

Per its labelling it contains dexmedetomidine and is used as a sedative for adults in intensive care settings, and to help put patients to sleep and relieve pain around treatment. SDO Pharma has not independently verified the manufacturer’s claims and does not claim any specific regulatory approval unless independently confirmed.

Its labelling describes it as given only by a doctor, into the veins, in an intensive care setting, with heart rate, breathing, blood pressure, and oxygen monitored. It is never self-administered.

Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.

Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.

Explore More

Related Product Categories

SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.

View Products & Services